{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T09:38:42Z","timestamp":1790933922385,"version":"4.1.0"},"reference-count":87,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AIDS Res Ther"],"published-print":{"date-parts":[[2008,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Human T-cell leukemia virus type-1 (HTLV-1) induces adult T-cell leukemia\/lymphoma (ATL\/L), a fatal lymphoproliferative disorder, and HTLV-1-associated myelopathy\/tropical spastic paraparesis (HAM\/TSP), a chronic progressive disease of the central nervous system after a long period of latent infection. Although the mechanism of transformation and leukemogenesis is not fully elucidated, there is evidence to suggest that the viral oncoprotein Tax plays a crucial role in these processes through the regulation of several pathways including NF-\u03baB and the cell cycle pathways. The observation that NF-\u03baB, which is strongly induced by Tax, is indispensable for the maintenance of the malignant phenotype of HTLV-1 by regulating the expression of various genes involved in cell cycle regulation and inhibition of apoptosis provides a possible molecular target for these infected cells. To develop potential new therapeutic strategies for HTLV-1 infected cells, in this present study, we initially screened a battery of NF-\u03baB and CDK inhibitors (total of 35 compounds) to examine their effects on the growth and survival of infected T-cell lines. Two drugs namely BMS-345541 and Purvalanol A exhibited higher levels of growth inhibition and apoptosis in infected cell as compared to uninfected cells. BMS-345541 inhibited IKK\u03b2 kinase activity from HTLV-1 infected cells with an IC<jats:sub>50<\/jats:sub> (the 50% of inhibitory concentration) value of 50 nM compared to 500 nM from control cells as measured by <jats:italic>in vitro<\/jats:italic> kinase assays. The effects of Purvalanol A were associated with suppression of CDK2\/cyclin E complex activity as previously shown by us. Combination of both BMS-345541 and Purvalanol A showed a reduced level of HTLV-1 p19 Gag production in cell culture. The apparent apoptosis in these infected cells were associated with increased caspase-3 activity and PARP cleavage. The potent and selective apoptotic effects of these drugs suggest that both BMS-345541 and Purvalanol A, which target both NF-\u03baB and CDK complex and the G1\/S border, might be promising new agents in the treatment of these infected patients.<\/jats:p>","DOI":"10.1186\/1742-6405-5-12","type":"journal-article","created":{"date-parts":[[2008,7,24]],"date-time":"2008-07-24T18:13:31Z","timestamp":1216923211000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Two specific drugs, BMS-345541 and purvalanol A induce apoptosis of HTLV-1 infected cells through inhibition of the NF-kappaB and cell cycle pathways"],"prefix":"10.1186","volume":"5","author":[{"given":"Emmanuel","family":"Agbottah","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-I","family":"Yeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reem","family":"Berro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zachary","family":"Klase","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caitlin","family":"Pedati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyleen","family":"Kehn-Hall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weilin","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatah","family":"Kashanchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2008,6,10]]},"reference":[{"key":"85_CR1","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/S1473-3099(07)70081-6","volume":"7","author":"K Verdonck","year":"2007","unstructured":"Verdonck K, Gonzalez E, Van Dooren S, Vandamme AM, Vanham G, Gotuzzo E: Human T-lymphotropic virus 1: recent knowledge about an ancient infection. Lancet Infect Dis. 2007, 7: 266-281. 10.1016\/S1473-3099(07)70081-6","journal-title":"Lancet Infect Dis"},{"key":"85_CR2","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/nrc2111","volume":"7","author":"M Matsuoka","year":"2007","unstructured":"Matsuoka M, Jeang KT: Human T-cell leukaemia virus type 1 (HTLV-1) infectivity and cellular transformation. Nat Rev Cancer. 2007, 7: 270-280. 10.1038\/nrc2111","journal-title":"Nat Rev Cancer"},{"key":"85_CR3","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1532\/IJH97.07087","volume":"86","author":"JM Peloponese Jr.","year":"2007","unstructured":"Peloponese JM, Kinjo T, Jeang KT: Human T-cell leukemia virus type 1 Tax and cellular transformation. Int J Hematol. 2007, 86: 101-106. 10.1532\/IJH97.07087","journal-title":"Int J Hematol"},{"key":"85_CR4","first-page":"3099","volume":"9","author":"T Suzuki","year":"1994","unstructured":"Suzuki T, Hirai H, Yoshida M: Tax protein of HTLV-1 interacts with the Rel homology domain of NF-kappa B p65 and c-Rel proteins bound to the NF-kappa B binding site and activates transcription. Oncogene. 1994, 9: 3099-3105.","journal-title":"Oncogene"},{"key":"85_CR5","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1016\/S0092-8674(00)81447-6","volume":"93","author":"MJ Yin","year":"1998","unstructured":"Yin MJ, Christerson LB, Yamamoto Y, Kwak YT, Xu S, Mercurio F, Barbosa M, Cobb MH, Gaynor RB: HTLV-I Tax protein binds to MEKK1 to stimulate IkappaB kinase activity and NF-kappaB activation. Cell. 1998, 93: 875-884. 10.1016\/S0092-8674(00)81447-6","journal-title":"Cell"},{"key":"85_CR6","doi-asserted-by":"publisher","first-page":"6805","DOI":"10.1093\/emboj\/20.23.6805","volume":"20","author":"G Xiao","year":"2001","unstructured":"Xiao G, Cvijic ME, Fong A, Harhaj EW, Uhlik MT, Waterfield M, Sun SC: Retroviral oncoprotein Tax induces processing of NF-kappaB2\/p100 in T cells: evidence for the involvement of IKKalpha. Embo J. 2001, 20: 6805-6815. 10.1093\/emboj\/20.23.6805","journal-title":"Embo J"},{"key":"85_CR7","doi-asserted-by":"crossref","first-page":"4269","DOI":"10.1002\/j.1460-2075.1993.tb06111.x","volume":"12","author":"C Caron","year":"1993","unstructured":"Caron C, Rousset R, Beraud C, Moncollin V, Egly JM, Jalinot P: Functional and biochemical interaction of the HTLV-I Tax1 transactivator with TBP. Embo J. 1993, 12: 4269-4278.","journal-title":"Embo J"},{"key":"85_CR8","doi-asserted-by":"crossref","first-page":"4656","DOI":"10.1128\/MCB.16.9.4656","volume":"16","author":"KE Clemens","year":"1996","unstructured":"Clemens KE, Piras G, Radonovich MF, Choi KS, Duvall JF, DeJong J, Roeder R, Brady JN: Interaction of the human T-cell lymphotropic virus type 1 tax transactivator with transcription factor IIA. Mol Cell Biol. 1996, 16: 4656-4664.","journal-title":"Mol Cell Biol"},{"key":"85_CR9","doi-asserted-by":"crossref","first-page":"9396","DOI":"10.1128\/JVI.72.11.9396-9399.1998","volume":"72","author":"MA Colgin","year":"1998","unstructured":"Colgin MA, Nyborg JK: The human T-cell leukemia virus type 1 oncoprotein Tax inhibits the transcriptional activity of c-Myb through competition for the CREB binding protein. J Virol. 1998, 72: 9396-9399.","journal-title":"J Virol"},{"key":"85_CR10","doi-asserted-by":"publisher","first-page":"3470","DOI":"10.1128\/MCB.20.10.3470-3481.2000","volume":"20","author":"F Gachon","year":"2000","unstructured":"Gachon F, Thebault S, Peleraux A, Devaux C, Mesnard JM: Molecular interactions involved in the transactivation of the human T-cell leukemia virus type 1 promoter mediated by Tax and CREB-2 (ATF-4). Mol Cell Biol. 2000, 20: 3470-3481. 10.1128\/MCB.20.10.3470-3481.2000","journal-title":"Mol Cell Biol"},{"key":"85_CR11","doi-asserted-by":"crossref","first-page":"5052","DOI":"10.1128\/MCB.18.9.5052","volume":"18","author":"R Harrod","year":"1998","unstructured":"Harrod R, Tang Y, Nicot C, Lu HS, Vassilev A, Nakatani Y, Giam CZ: An exposed KID-like domain in human T-cell lymphotropic virus type 1 Tax is responsible for the recruitment of coactivators CBP\/p300. Mol Cell Biol. 1998, 18: 5052-5061.","journal-title":"Mol Cell Biol"},{"key":"85_CR12","doi-asserted-by":"publisher","first-page":"2155","DOI":"10.1038\/sj.onc.1203536","volume":"19","author":"C Nicot","year":"2000","unstructured":"Nicot C, Mahieux R, Opavsky R, Cereseto A, Wolff L, Brady JN, Franchini G: HTLV-I Tax transrepresses the human c-Myb promoter independently of its interaction with CBP or p300. Oncogene. 2000, 19: 2155-2164. 10.1038\/sj.onc.1203536","journal-title":"Oncogene"},{"key":"85_CR13","doi-asserted-by":"crossref","first-page":"3420","DOI":"10.1128\/jvi.69.6.3420-3432.1995","volume":"69","author":"MJ Yin","year":"1995","unstructured":"Yin MJ, Paulssen EJ, Seeler JS, Gaynor RB: Protein domains involved in both in vivo and in vitro interactions between human T-cell leukemia virus type I tax and CREB. J Virol. 1995, 69: 3420-3432.","journal-title":"J Virol"},{"key":"85_CR14","doi-asserted-by":"publisher","first-page":"5938","DOI":"10.1038\/sj.onc.1208973","volume":"24","author":"F Kashanchi","year":"2005","unstructured":"Kashanchi F, Brady JN: Transcriptional and post-transcriptional gene regulation of HTLV-1. Oncogene. 2005, 24: 5938-5951. 10.1038\/sj.onc.1208973","journal-title":"Oncogene"},{"key":"85_CR15","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.ccr.2004.09.003","volume":"6","author":"BB Aggarwal","year":"2004","unstructured":"Aggarwal BB: Nuclear factor-kappaB: the enemy within. Cancer Cell. 2004, 6: 203-208. 10.1016\/j.ccr.2004.09.003","journal-title":"Cancer Cell"},{"key":"85_CR16","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/S0070-2137(97)80006-4","volume":"35","author":"T Okamoto","year":"1997","unstructured":"Okamoto T, Sakurada S, Yang JP, Merin JP: Regulation of NF-kappa B and disease control: identification of a novel serine kinase and thioredoxin as effectors for signal transduction pathway for NF-kappa B activation. Curr Top Cell Regul. 1997, 35: 149-161.","journal-title":"Curr Top Cell Regul"},{"key":"85_CR17","doi-asserted-by":"publisher","first-page":"6817","DOI":"10.1038\/sj.onc.1209942","volume":"25","author":"DS Basseres","year":"2006","unstructured":"Basseres DS, Baldwin AS: Nuclear factor-kappaB and inhibitor of kappaB kinase pathways in oncogenic initiation and progression. Oncogene. 2006, 25: 6817-6830. 10.1038\/sj.onc.1209942","journal-title":"Oncogene"},{"key":"85_CR18","doi-asserted-by":"publisher","first-page":"6047","DOI":"10.1038\/sj.onc.1208979","volume":"24","author":"GP Taylor","year":"2005","unstructured":"Taylor GP, Matsuoka M: Natural history of adult T-cell leukemia\/lymphoma and approaches to therapy. Oncogene. 2005, 24: 6047-6057. 10.1038\/sj.onc.1208979","journal-title":"Oncogene"},{"key":"85_CR19","doi-asserted-by":"publisher","first-page":"S81","DOI":"10.1016\/S0092-8674(02)00703-1","volume":"109 Suppl","author":"S Ghosh","year":"2002","unstructured":"Ghosh S, Karin M: Missing pieces in the NF-kappaB puzzle. Cell. 2002, 109 Suppl: S81-96. 10.1016\/S0092-8674(02)00703-1","journal-title":"Cell"},{"key":"85_CR20","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1038\/nature02924","volume":"431","author":"E Pikarsky","year":"2004","unstructured":"Pikarsky E, Porat RM, Stein I, Abramovitch R, Amit S, Kasem S, Gutkovich-Pyest E, Urieli-Shoval S, Galun E, Ben-Neriah Y: NF-kappaB functions as a tumour promoter in inflammation-associated cancer. Nature. 2004, 431: 461-466. 10.1038\/nature02924","journal-title":"Nature"},{"key":"85_CR21","doi-asserted-by":"publisher","first-page":"6680","DOI":"10.1038\/sj.onc.1209954","volume":"25","author":"TD Gilmore","year":"2006","unstructured":"Gilmore TD: Introduction to NF-kappaB: players, pathways, perspectives. Oncogene. 2006, 25: 6680-6684. 10.1038\/sj.onc.1209954","journal-title":"Oncogene"},{"key":"85_CR22","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1038\/nrc780","volume":"2","author":"M Karin","year":"2002","unstructured":"Karin M, Cao Y, Greten FR, Li ZW: NF-kappaB in cancer: from innocent bystander to major culprit. Nat Rev Cancer. 2002, 2: 301-310. 10.1038\/nrc780","journal-title":"Nat Rev Cancer"},{"key":"85_CR23","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1046\/j.1365-2958.1998.00851.x","volume":"28","author":"K Schesser","year":"1998","unstructured":"Schesser K, Spiik AK, Dukuzumuremyi JM, Neurath MF, Pettersson S, Wolf-Watz H: The yopJ locus is required for Yersinia-mediated inhibition of NF-kappaB activation and cytokine expression: YopJ contains a eukaryotic SH2-like domain that is essential for its repressive activity. Mol Microbiol. 1998, 28: 1067-1079. 10.1046\/j.1365-2958.1998.00851.x","journal-title":"Mol Microbiol"},{"key":"85_CR24","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1016\/S1097-2765(02)00697-4","volume":"10","author":"JL Pomerantz","year":"2002","unstructured":"Pomerantz JL, Baltimore D: Two pathways to NF-kappaB. Mol Cell. 2002, 10: 693-695. 10.1016\/S1097-2765(02)00697-4","journal-title":"Mol Cell"},{"key":"85_CR25","doi-asserted-by":"publisher","first-page":"1828","DOI":"10.1182\/blood-2002-01-0151","volume":"100","author":"N Mori","year":"2002","unstructured":"Mori N, Yamada Y, Ikeda S, Yamasaki Y, Tsukasaki K, Tanaka Y, Tomonaga M, Yamamoto N, Fujii M: Bay 11-7082 inhibits transcription factor NF-kappaB and induces apoptosis of HTLV-I-infected T-cell lines and primary adult T-cell leukemia cells. Blood. 2002, 100: 1828-1834. 10.1182\/blood-2002-01-0151","journal-title":"Blood"},{"key":"85_CR26","first-page":"3915","volume":"95","author":"N Mori","year":"2000","unstructured":"Mori N, Fujii M, Iwai K, Ikeda S, Yamasaki Y, Hata T, Yamada Y, Tanaka Y, Tomonaga M, Yamamoto N: Constitutive activation of transcription factor AP-1 in primary adult T-cell leukemia cells. Blood. 2000, 95: 3915-3921.","journal-title":"Blood"},{"key":"85_CR27","doi-asserted-by":"publisher","first-page":"4202","DOI":"10.1038\/sj.emboj.7600391","volume":"23","author":"G Bonizzi","year":"2004","unstructured":"Bonizzi G, Bebien M, Otero DC, Johnson-Vroom KE, Cao Y, Vu D, Jegga AG, Aronow BJ, Ghosh G, Rickert RC, Karin M: Activation of IKKalpha target genes depends on recognition of specific kappaB binding sites by RelB:p52 dimers. Embo J. 2004, 23: 4202-4210. 10.1038\/sj.emboj.7600391","journal-title":"Embo J"},{"key":"85_CR28","doi-asserted-by":"publisher","first-page":"23278","DOI":"10.1074\/jbc.M300106200","volume":"278","author":"E Derudder","year":"2003","unstructured":"Derudder E, Dejardin E, Pritchard LL, Green DR, Korner M, Baud V: RelB\/p50 dimers are differentially regulated by tumor necrosis factor-alpha and lymphotoxin-beta receptor activation: critical roles for p100. J Biol Chem. 2003, 278: 23278-23284. 10.1074\/jbc.M300106200","journal-title":"J Biol Chem"},{"key":"85_CR29","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1093\/emboj\/cdg004","volume":"22","author":"ZB Yilmaz","year":"2003","unstructured":"Yilmaz ZB, Weih DS, Sivakumar V, Weih F: RelB is required for Peyer's patch development: differential regulation of p52-RelB by lymphotoxin and TNF. Embo J. 2003, 22: 121-130. 10.1093\/emboj\/cdg004","journal-title":"Embo J"},{"key":"85_CR30","doi-asserted-by":"publisher","first-page":"6812","DOI":"10.4049\/jimmunol.166.11.6812","volume":"166","author":"RF Schwabe","year":"2001","unstructured":"Schwabe RF, Schnabl B, Kweon YO, Brenner DA: CD40 activates NF-kappa B and c-Jun N-terminal kinase and enhances chemokine secretion on activated human hepatic stellate cells. J Immunol. 2001, 166: 6812-6819.","journal-title":"J Immunol"},{"key":"85_CR31","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1593\/neo.03388","volume":"6","author":"N Hironaka","year":"2004","unstructured":"Hironaka N, Mochida K, Mori N, Maeda M, Yamamoto N, Yamaoka S: Tax-independent constitutive IkappaB kinase activation in adult T-cell leukemia cells. Neoplasia. 2004, 6: 266-278. 10.1593\/neo.03388","journal-title":"Neoplasia"},{"key":"85_CR32","doi-asserted-by":"publisher","first-page":"15297","DOI":"10.1074\/jbc.274.22.15297","volume":"274","author":"ZL Chu","year":"1999","unstructured":"Chu ZL, Shin YA, Yang JM, DiDonato JA, Ballard DW: IKKgamma mediates the interaction of cellular IkappaB kinases with the tax transforming protein of human T cell leukemia virus type 1. J Biol Chem. 1999, 274: 15297-15300. 10.1074\/jbc.274.22.15297","journal-title":"J Biol Chem"},{"key":"85_CR33","doi-asserted-by":"publisher","first-page":"22911","DOI":"10.1074\/jbc.274.33.22911","volume":"274","author":"EW Harhaj","year":"1999","unstructured":"Harhaj EW, Sun SC: IKKgamma serves as a docking subunit of the IkappaB kinase (IKK) and mediates interaction of IKK with the human T-cell leukemia virus Tax protein. J Biol Chem. 1999, 274: 22911-22914. 10.1074\/jbc.274.33.22911","journal-title":"J Biol Chem"},{"key":"85_CR34","doi-asserted-by":"publisher","first-page":"17402","DOI":"10.1074\/jbc.274.25.17402","volume":"274","author":"DY Jin","year":"1999","unstructured":"Jin DY, Giordano V, Kibler KV, Nakano H, Jeang KT: Role of adapter function in oncoprotein-mediated activation of NF-kappaB. Human T-cell leukemia virus type I Tax interacts directly with IkappaB kinase gamma. J Biol Chem. 1999, 274: 17402-17405. 10.1074\/jbc.274.25.17402","journal-title":"J Biol Chem"},{"key":"85_CR35","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1016\/S0092-8674(00)81466-X","volume":"93","author":"S Yamaoka","year":"1998","unstructured":"Yamaoka S, Courtois G, Bessia C, Whiteside ST, Weil R, Agou F, Kirk HE, Kay RJ, Israel A: Complementation cloning of NEMO, a component of the IkappaB kinase complex essential for NF-kappaB activation. Cell. 1998, 93: 1231-1240. 10.1016\/S0092-8674(00)81466-X","journal-title":"Cell"},{"key":"85_CR36","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1201\/9780203219973.ch7","volume-title":"Molecular pathomechanisms and new trends in drug development","author":"ABB Karunagaran D.","year":"2002","unstructured":"Karunagaran D. ABB: Transcription factors as targets fr the drug development. Molecular pathomechanisms and new trends in drug development. Edited by: Keri G. TI. 2002, 76-91. New York, NY, Harwood Academic Publisher,2002:76-91."},{"key":"85_CR37","first-page":"2360","volume":"93","author":"N Mori","year":"1999","unstructured":"Mori N, Fujii M, Ikeda S, Yamada Y, Tomonaga M, Ballard DW, Yamamoto N: Constitutive activation of NF-kappaB in primary adult T-cell leukemia cells. Blood. 1999, 93: 2360-2368.","journal-title":"Blood"},{"key":"85_CR38","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1182\/blood.V96.1.275.013k43_275_281","volume":"96","author":"C Nicot","year":"2000","unstructured":"Nicot C, Mahieux R, Takemoto S, Franchini G: Bcl-X(L) is up-regulated by HTLV-I and HTLV-II in vitro and in ex vivo ATLL samples. Blood. 2000, 96: 275-281.","journal-title":"Blood"},{"key":"85_CR39","doi-asserted-by":"publisher","first-page":"5286","DOI":"10.1128\/JVI.77.9.5286-5294.2003","volume":"77","author":"MZ Dewan","year":"2003","unstructured":"Dewan MZ, Terashima K, Taruishi M, Hasegawa H, Ito M, Tanaka Y, Mori N, Sata T, Koyanagi Y, Maeda M, Kubuki Y, Okayama A, Fujii M, Yamamoto N: Rapid tumor formation of human T-cell leukemia virus type 1-infected cell lines in novel NOD-SCID\/gammac(null) mice: suppression by an inhibitor against NF-kappaB. J Virol. 2003, 77: 5286-5294. 10.1128\/JVI.77.9.5286-5294.2003","journal-title":"J Virol"},{"key":"85_CR40","doi-asserted-by":"publisher","first-page":"1382","DOI":"10.1093\/carcin\/bgi095","volume":"26","author":"T Ohsugi","year":"2005","unstructured":"Ohsugi T, Horie R, Kumasaka T, Ishida A, Ishida T, Yamaguchi K, Watanabe T, Umezawa K, Urano T: In vivo antitumor activity of the NF-kappaB inhibitor dehydroxymethylepoxyquinomicin in a mouse model of adult T-cell leukemia. Carcinogenesis. 2005, 26: 1382-1388. 10.1093\/carcin\/bgi095","journal-title":"Carcinogenesis"},{"key":"85_CR41","doi-asserted-by":"publisher","first-page":"2462","DOI":"10.1182\/blood-2004-09-3646","volume":"106","author":"M Watanabe","year":"2005","unstructured":"Watanabe M, Ohsugi T, Shoda M, Ishida T, Aizawa S, Maruyama-Nagai M, Utsunomiya A, Koga S, Yamada Y, Kamihira S, Okayama A, Kikuchi H, Uozumi K, Yamaguchi K, Higashihara M, Umezawa K, Watanabe T, Horie R: Dual targeting of transformed and untransformed HTLV-1-infected T cells by DHMEQ, a potent and selective inhibitor of NF-kappaB, as a strategy for chemoprevention and therapy of adult T-cell leukemia. Blood. 2005, 106: 2462-2471. 10.1182\/blood-2004-09-3646","journal-title":"Blood"},{"key":"85_CR42","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.leukres.2005.06.001","volume":"30","author":"T Ohsugi","year":"2006","unstructured":"Ohsugi T, Kumasaka T, Ishida A, Ishida T, Horie R, Watanabe T, Umezawa K, Yamaguchi K: In vitro and in vivo antitumor activity of the NF-kappaB inhibitor DHMEQ in the human T-cell leukemia virus type I-infected cell line, HUT-102. Leuk Res. 2006, 30: 90-97. 10.1016\/j.leukres.2005.06.001","journal-title":"Leuk Res"},{"key":"85_CR43","first-page":"2849","volume":"96","author":"ME El-Sabban","year":"2000","unstructured":"El-Sabban ME, Nasr R, Dbaibo G, Hermine O, Abboushi N, Quignon F, Ameisen JC, Bex F, de The H, Bazarbachi A: Arsenic-interferon-alpha-triggered apoptosis in HTLV-I transformed cells is associated with tax down-regulation and reversal of NF-kappa B activation. Blood. 2000, 96: 2849-2855.","journal-title":"Blood"},{"key":"85_CR44","doi-asserted-by":"publisher","first-page":"4576","DOI":"10.1182\/blood-2002-09-2986","volume":"101","author":"R Nasr","year":"2003","unstructured":"Nasr R, Rosenwald A, El-Sabban ME, Arnulf B, Zalloua P, Lepelletier Y, Bex F, Hermine O, Staudt L, de The H, Bazarbachi A: Arsenic\/interferon specifically reverses 2 distinct gene networks critical for the survival of HTLV-1-infected leukemic cells. Blood. 2003, 101: 4576-4582. 10.1182\/blood-2002-09-2986","journal-title":"Blood"},{"key":"85_CR45","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1038\/sj.leu.2403400","volume":"18","author":"Y Satou","year":"2004","unstructured":"Satou Y, Nosaka K, Koya Y, Yasunaga JI, Toyokuni S, Matsuoka M: Proteasome inhibitor, bortezomib, potently inhibits the growth of adult T-cell leukemia cells both in vivo and in vitro. Leukemia. 2004, 18: 1357-1363. 10.1038\/sj.leu.2403400","journal-title":"Leukemia"},{"key":"85_CR46","doi-asserted-by":"publisher","first-page":"31851","DOI":"10.1074\/jbc.M105195200","volume":"276","author":"FJ Lemoine","year":"2001","unstructured":"Lemoine FJ, Marriott SJ: Accelerated G(1) phase progression induced by the human T cell leukemia virus type I (HTLV-I) Tax oncoprotein. J Biol Chem. 2001, 276: 31851-31857. 10.1074\/jbc.M105195200","journal-title":"J Biol Chem"},{"key":"85_CR47","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1002\/j.1460-2075.1996.tb00505.x","volume":"15","author":"T Suzuki","year":"1996","unstructured":"Suzuki T, Kitao S, Matsushime H, Yoshida M: HTLV-1 Tax protein interacts with cyclin-dependent kinase inhibitor p16INK4A and counteracts its inhibitory activity towards CDK4. Embo J. 1996, 15: 1607-1614.","journal-title":"Embo J"},{"key":"85_CR48","doi-asserted-by":"crossref","first-page":"5731","DOI":"10.1128\/jvi.70.8.5731-5734.1996","volume":"70","author":"SF Parker","year":"1996","unstructured":"Parker SF, Perkins ND, Gitlin SD, Nabel GJ: A cooperative interaction of human T-cell leukemia virus type 1 Tax with the p21 cyclin-dependent kinase inhibitor activates the human immunodeficiency virus type 1 enhancer. J Virol. 1996, 70: 5731-5734.","journal-title":"J Virol"},{"key":"85_CR49","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.1128\/jvi.71.3.1956-1962.1997","volume":"71","author":"KG Low","year":"1997","unstructured":"Low KG, Dorner LF, Fernando DB, Grossman J, Jeang KT, Comb MJ: Human T-cell leukemia virus type 1 Tax releases cell cycle arrest induced by p16INK4a. J Virol. 1997, 71: 1956-1962.","journal-title":"J Virol"},{"key":"85_CR50","doi-asserted-by":"publisher","first-page":"31991","DOI":"10.1074\/jbc.R400009200","volume":"279","author":"KT Jeang","year":"2004","unstructured":"Jeang KT, Giam CZ, Majone F, Aboud M: Life, death, and tax: role of HTLV-I oncoprotein in genetic instability and cellular transformation. J Biol Chem. 2004, 279: 31991-31994. 10.1074\/jbc.R400009200","journal-title":"J Biol Chem"},{"key":"85_CR51","doi-asserted-by":"publisher","first-page":"5986","DOI":"10.1038\/sj.onc.1208976","volume":"24","author":"SJ Marriott","year":"2005","unstructured":"Marriott SJ, Semmes OJ: Impact of HTLV-I Tax on cell cycle progression and the cellular DNA damage repair response. Oncogene. 2005, 24: 5986-5995. 10.1038\/sj.onc.1208976","journal-title":"Oncogene"},{"key":"85_CR52","doi-asserted-by":"publisher","first-page":"7270","DOI":"10.1128\/JVI.74.16.7270-7283.2000","volume":"74","author":"C de La Fuente","year":"2000","unstructured":"de La Fuente C, Santiago F, Chong SY, Deng L, Mayhood T, Fu P, Stein D, Denny T, Coffman F, Azimi N, Mahieux R, Kashanchi F: Overexpression of p21(waf1) in human T-cell lymphotropic virus type 1-infected cells and its association with cyclin A\/cdk2. J Virol. 2000, 74: 7270-7283. 10.1128\/JVI.74.16.7270-7283.2000","journal-title":"J Virol"},{"key":"85_CR53","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1182\/blood.V88.5.1551.1551","volume":"88","author":"A Cereseto","year":"1996","unstructured":"Cereseto A, Diella F, Mulloy JC, Cara A, Michieli P, Grassmann R, Franchini G, Klotman ME: p53 functional impairment and high p21waf1\/cip1 expression in human T-cell lymphotropic\/leukemia virus type I-transformed T cells. Blood. 1996, 88: 1551-1560.","journal-title":"Blood"},{"key":"85_CR54","doi-asserted-by":"crossref","first-page":"6348","DOI":"10.1128\/JVI.72.8.6348-6355.1998","volume":"72","author":"CA Pise-Masison","year":"1998","unstructured":"Pise-Masison CA, Radonovich M, Sakaguchi K, Appella E, Brady JN: Phosphorylation of p53: a novel pathway for p53 inactivation in human T-cell lymphotropic virus type 1-transformed cells. J Virol. 1998, 72: 6348-6355.","journal-title":"J Virol"},{"key":"85_CR55","doi-asserted-by":"publisher","first-page":"3377","DOI":"10.1128\/MCB.20.10.3377-3386.2000","volume":"20","author":"CA Pise-Masison","year":"2000","unstructured":"Pise-Masison CA, Mahieux R, Jiang H, Ashcroft M, Radonovich M, Duvall J, Guillerm C, Brady JN: Inactivation of p53 by human T-cell lymphotropic virus type 1 Tax requires activation of the NF-kappaB pathway and is dependent on p53 phosphorylation. Mol Cell Biol. 2000, 20: 3377-3386. 10.1128\/MCB.20.10.3377-3386.2000","journal-title":"Mol Cell Biol"},{"key":"85_CR56","doi-asserted-by":"crossref","first-page":"3620","DOI":"10.1128\/MCB.18.6.3620","volume":"18","author":"C Neuveut","year":"1998","unstructured":"Neuveut C, Low KG, Maldarelli F, Schmitt I, Majone F, Grassmann R, Jeang KT: Human T-cell leukemia virus type 1 Tax and cell cycle progression: role of cyclin D-cdk and p110Rb. Mol Cell Biol. 1998, 18: 3620-3632.","journal-title":"Mol Cell Biol"},{"key":"85_CR57","first-page":"1645","volume":"12","author":"T Akagi","year":"1996","unstructured":"Akagi T, Ono H, Shimotohno K: Expression of cell-cycle regulatory genes in HTLV-I infected T-cell lines: possible involvement of Tax1 in the altered expression of cyclin D2, p18Ink4 and p21Waf1\/Cip1\/Sdi1. Oncogene. 1996, 12: 1645-1652.","journal-title":"Oncogene"},{"key":"85_CR58","doi-asserted-by":"publisher","first-page":"1695","DOI":"10.1089\/08892220050193164","volume":"16","author":"C de La Fuente","year":"2000","unstructured":"de La Fuente C, Deng L, Santiago F, Arce L, Wang L, Kashanchi F: Gene expression array of HTLV type 1-infected T cells: Up-regulation of transcription factors and cell cycle genes. AIDS Res Hum Retroviruses. 2000, 16: 1695-1700. 10.1089\/08892220050193164","journal-title":"AIDS Res Hum Retroviruses"},{"key":"85_CR59","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1038\/sj.onc.1204198","volume":"20","author":"Y Huang","year":"2001","unstructured":"Huang Y, Ohtani K, Iwanaga R, Matsumura Y, Nakamura M: Direct trans-activation of the human cyclin D2 gene by the oncogene product Tax of human T-cell leukemia virus type I. Oncogene. 2001, 20: 1094-1102. 10.1038\/sj.onc.1204198","journal-title":"Oncogene"},{"key":"85_CR60","doi-asserted-by":"crossref","first-page":"9917","DOI":"10.1128\/JVI.73.12.9917-9927.1999","volume":"73","author":"F Santiago","year":"1999","unstructured":"Santiago F, Clark E, Chong S, Molina C, Mozafari F, Mahieux R, Fujii M, Azimi N, Kashanchi F: Transcriptional up-regulation of the cyclin D2 gene and acquisition of new cyclin-dependent kinase partners in human T-cell leukemia virus type 1-infected cells. J Virol. 1999, 73: 9917-9927.","journal-title":"J Virol"},{"key":"85_CR61","doi-asserted-by":"publisher","first-page":"2055","DOI":"10.1038\/sj.onc.1204304","volume":"20","author":"R Iwanaga","year":"2001","unstructured":"Iwanaga R, Ohtani K, Hayashi T, Nakamura M: Molecular mechanism of cell cycle progression induced by the oncogene product Tax of human T-cell leukemia virus type I. Oncogene. 2001, 20: 2055-2067. 10.1038\/sj.onc.1204304","journal-title":"Oncogene"},{"key":"85_CR62","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/1742-4690-1-6","volume":"1","author":"K Kehn","year":"2004","unstructured":"Kehn K, Deng L, de la Fuente C, Strouss K, Wu K, Maddukuri A, Baylor S, Rufner R, Pumfery A, Bottazzi ME, Kashanchi F: The role of cyclin D2 and p21\/waf1 in human T-cell leukemia virus type 1 infected cells. Retrovirology. 2004, 1: 6- 10.1186\/1742-4690-1-6","journal-title":"Retrovirology"},{"key":"85_CR63","first-page":"269","volume":"10","author":"K Chlichlia","year":"1995","unstructured":"Chlichlia K, Moldenhauer G, Daniel PT, Busslinger M, Gazzolo L, Schirrmacher V, Khazaie K: Immediate effects of reversible HTLV-1 tax function: T-cell activation and apoptosis. Oncogene. 1995, 10: 269-277.","journal-title":"Oncogene"},{"key":"85_CR64","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1074\/jbc.M209677200","volume":"278","author":"JR Burke","year":"2003","unstructured":"Burke JR, Pattoli MA, Gregor KR, Brassil PJ, MacMaster JF, McIntyre KW, Yang X, Iotzova VS, Clarke W, Strnad J, Qiu Y, Zusi FC: BMS-345541 is a highly selective inhibitor of I kappa B kinase that binds at an allosteric site of the enzyme and blocks NF-kappa B-dependent transcription in mice. J Biol Chem. 2003, 278: 1450-1456. 10.1074\/jbc.M209677200","journal-title":"J Biol Chem"},{"key":"85_CR65","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1158\/1078-0432.CCR-05-1220","volume":"12","author":"J Yang","year":"2006","unstructured":"Yang J, Amiri KI, Burke JR, Schmid JA, Richmond A: BMS-345541 targets inhibitor of kappaB kinase and induces apoptosis in melanoma: involvement of nuclear factor kappaB and mitochondria pathways. Clin Cancer Res. 2006, 12: 950-960. 10.1158\/1078-0432.CCR-05-1220","journal-title":"Clin Cancer Res"},{"key":"85_CR66","first-page":"2611","volume":"12","author":"CJ Petropoulos","year":"1996","unstructured":"Petropoulos CJ, Givol I, Hughes SH: Comparative analysis of the structure and function of the chicken c-myc and v-myc genes: v-myc is a more potent inducer of cell proliferation and apoptosis than c-myc. Oncogene. 1996, 12: 2611-2621.","journal-title":"Oncogene"},{"key":"85_CR67","doi-asserted-by":"publisher","first-page":"2141","DOI":"10.1073\/pnas.88.6.2141","volume":"88","author":"F Mauxion","year":"1991","unstructured":"Mauxion F, Jamieson C, Yoshida M, Arai K, Sen R: Comparison of constitutive and inducible transcriptional enhancement mediated by kappa B-related sequences: modulation of activity in B cells by human T-cell leukemia virus type I tax gene. Proc Natl Acad Sci U S A. 1991, 88: 2141-2145. 10.1073\/pnas.88.6.2141","journal-title":"Proc Natl Acad Sci U S A"},{"key":"85_CR68","doi-asserted-by":"crossref","first-page":"6892","DOI":"10.1128\/jvi.65.12.6892-6899.1991","volume":"65","author":"N Arima","year":"1991","unstructured":"Arima N, Molitor JA, Smith MR, Kim JH, Daitoku Y, Greene WC: Human T-cell leukemia virus type I Tax induces expression of the Rel-related family of kappa B enhancer-binding proteins: evidence for a pretranslational component of regulation. J Virol. 1991, 65: 6892-6899.","journal-title":"J Virol"},{"key":"85_CR69","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1038\/376037a0","volume":"376","author":"DW Nicholson","year":"1995","unstructured":"Nicholson DW, Ali A, Thornberry NA, Vaillancourt JP, Ding CK, Gallant M, Gareau Y, Griffin PR, Labelle M, Lazebnik YA: Identification and inhibition of the ICE\/CED-3 protease necessary for mammalian apoptosis. Nature. 1995, 376: 37-43. 10.1038\/376037a0","journal-title":"Nature"},{"key":"85_CR70","doi-asserted-by":"publisher","first-page":"13432","DOI":"10.1074\/jbc.272.20.13432","volume":"272","author":"Z Han","year":"1997","unstructured":"Han Z, Hendrickson EA, Bremner TA, Wyche JH: A sequential two-step mechanism for the production of the mature p17:p12 form of caspase-3 in vitro. J Biol Chem. 1997, 272: 13432-13436. 10.1074\/jbc.272.20.13432","journal-title":"J Biol Chem"},{"key":"85_CR71","doi-asserted-by":"publisher","first-page":"7703","DOI":"10.1073\/pnas.89.16.7703","volume":"89","author":"WG Rice","year":"1992","unstructured":"Rice WG, Hillyer CD, Harten B, Schaeffer CA, Dorminy M, Lackey DA, Kirsten E, Mendeleyev J, Buki KG, Hakam A: Induction of endonuclease-mediated apoptosis in tumor cells by C-nitroso-substituted ligands of poly(ADP-ribose) polymerase. Proc Natl Acad Sci U S A. 1992, 89: 7703-7707. 10.1073\/pnas.89.16.7703","journal-title":"Proc Natl Acad Sci U S A"},{"key":"85_CR72","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1038\/371346a0","volume":"371","author":"YA Lazebnik","year":"1994","unstructured":"Lazebnik YA, Kaufmann SH, Desnoyers S, Poirier GG, Earnshaw WC: Cleavage of poly(ADP-ribose) polymerase by a proteinase with properties like ICE. Nature. 1994, 371: 346-347. 10.1038\/371346a0","journal-title":"Nature"},{"key":"85_CR73","first-page":"3976","volume":"53","author":"SH Kaufmann","year":"1993","unstructured":"Kaufmann SH, Desnoyers S, Ottaviano Y, Davidson NE, Poirier GG: Specific proteolytic cleavage of poly(ADP-ribose) polymerase: an early marker of chemotherapy-induced apoptosis. Cancer Res. 1993, 53: 3976-3985.","journal-title":"Cancer Res"},{"key":"85_CR74","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1101\/gad.13.12.1501","volume":"13","author":"CJ Sherr","year":"1999","unstructured":"Sherr CJ, Roberts JM: CDK inhibitors: positive and negative regulators of G1-phase progression. Genes Dev. 1999, 13: 1501-1512. 10.1101\/gad.13.12.1501","journal-title":"Genes Dev"},{"key":"85_CR75","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1002\/ijc.10125","volume":"97","author":"N Villerbu","year":"2002","unstructured":"Villerbu N, Gaben AM, Redeuilh G, Mester J: Cellular effects of purvalanol A: a specific inhibitor of cyclin-dependent kinase activities. Int J Cancer. 2002, 97: 761-769. 10.1002\/ijc.10125","journal-title":"Int J Cancer"},{"key":"85_CR76","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1042\/bj20021535","volume":"371","author":"J Bain","year":"2003","unstructured":"Bain J, McLauchlan H, Elliott M, Cohen P: The specificities of protein kinase inhibitors: an update. Biochem J. 2003, 371: 199-204. 10.1042\/BJ20021535","journal-title":"Biochem J"},{"key":"85_CR77","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1126\/science.281.5376.533","volume":"281","author":"NS Gray","year":"1998","unstructured":"Gray NS, Wodicka L, Thunnissen AM, Norman TC, Kwon S, Espinoza FH, Morgan DO, Barnes G, LeClerc S, Meijer L, Kim SH, Lockhart DJ, Schultz PG: Exploiting chemical libraries, structure, and genomics in the search for kinase inhibitors. Science. 1998, 281: 533-538. 10.1126\/science.281.5376.533","journal-title":"Science"},{"key":"85_CR78","doi-asserted-by":"publisher","first-page":"4467","DOI":"10.1158\/0008-5472.CAN-05-0559","volume":"65","author":"M Matsuoka","year":"2005","unstructured":"Matsuoka M, Jeang KT: Human T-cell leukemia virus type I at age 25: a progress report. Cancer Res. 2005, 65: 4467-4470. 10.1158\/0008-5472.CAN-05-0559","journal-title":"Cancer Res"},{"key":"85_CR79","doi-asserted-by":"publisher","first-page":"5952","DOI":"10.1038\/sj.onc.1208969","volume":"24","author":"SC Sun","year":"2005","unstructured":"Sun SC, Yamaoka S: Activation of NF-kappaB by HTLV-I and implications for cell transformation. Oncogene. 2005, 24: 5952-5964. 10.1038\/sj.onc.1208969","journal-title":"Oncogene"},{"key":"85_CR80","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1128\/JVI.78.1.104-115.2004","volume":"78","author":"A Kudoh","year":"2004","unstructured":"Kudoh A, Daikoku T, Sugaya Y, Isomura H, Fujita M, Kiyono T, Nishiyama Y, Tsurumi T: Inhibition of S-phase cyclin-dependent kinase activity blocks expression of Epstein-Barr virus immediate-early and early genes, preventing viral lytic replication. J Virol. 2004, 78: 104-115. 10.1128\/JVI.78.1.104-115.2004","journal-title":"J Virol"},{"key":"85_CR81","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1023\/A:1016555821581","volume":"237","author":"L Wang","year":"2002","unstructured":"Wang L, Deng L, Wu K, de la Fuente C, Wang D, Kehn K, Maddukuri A, Baylor S, Santiago F, Agbottah E, Trigon S, Morange M, Mahieux R, Kashanchi F: Inhibition of HTLV-1 transcription by cyclin dependent kinase inhibitors. Mol Cell Biochem. 2002, 237: 137-153. 10.1023\/A:1016555821581","journal-title":"Mol Cell Biochem"},{"key":"85_CR82","doi-asserted-by":"publisher","first-page":"1744","DOI":"10.1056\/NEJM199506293322603","volume":"332","author":"PS Gill","year":"1995","unstructured":"Gill PS, Harrington W, Kaplan MH, Ribeiro RC, Bennett JM, Liebman HA, Bernstein-Singer M, Espina BM, Cabral L, Allen S: Treatment of adult T-cell leukemia-lymphoma with a combination of interferon alfa and zidovudine. N Engl J Med. 1995, 332: 1744-1748. 10.1056\/NEJM199506293322603","journal-title":"N Engl J Med"},{"key":"85_CR83","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.1056\/NEJM199506293322604","volume":"332","author":"O Hermine","year":"1995","unstructured":"Hermine O, Bouscary D, Gessain A, Turlure P, Leblond V, Franck N, Buzyn-Veil A, Rio B, Macintyre E, Dreyfus F: Brief report: treatment of adult T-cell leukemia-lymphoma with zidovudine and interferon alfa. N Engl J Med. 1995, 332: 1749-1751. 10.1056\/NEJM199506293322604","journal-title":"N Engl J Med"},{"issue":"Suppl 1","key":"85_CR84","doi-asserted-by":"publisher","first-page":"S186","DOI":"10.1097\/00042560-199600001-00028","volume":"13","author":"A Bazarbachi","year":"1996","unstructured":"Bazarbachi A, Hermine O: Treatment with a combination of zidovudine and alpha-interferon in naive and pretreated adult T-cell leukemia\/lymphoma patients. J Acquir Immune Defic Syndr Hum Retrovirol. 1996, 13 Suppl 1: S186-90. 10.1097\/00042560-199600001-00028","journal-title":"J Acquir Immune Defic Syndr Hum Retrovirol"},{"key":"85_CR85","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1038\/sj.thj.6200195","volume":"3","author":"O Hermine","year":"2002","unstructured":"Hermine O, Allard I, Levy V, Arnulf B, Gessain A, Bazarbachi A: A prospective phase II clinical trial with the use of zidovudine and interferon-alpha in the acute and lymphoma forms of adult T-cell leukemia\/lymphoma. Hematol J. 2002, 3: 276-282. 10.1038\/sj.thj.6200195","journal-title":"Hematol J"},{"key":"85_CR86","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1038\/sj.thj.6200374","volume":"5","author":"O Hermine","year":"2004","unstructured":"Hermine O, Dombret H, Poupon J, Arnulf B, Lefrere F, Rousselot P, Damaj G, Delarue R, Fermand JP, Brouet JC, Degos L, Varet B, de The H, Bazarbachi A: Phase II trial of arsenic trioxide and alpha interferon in patients with relapsed\/refractory adult T-cell leukemia\/lymphoma. Hematol J. 2004, 5: 130-134. 10.1038\/sj.thj.6200374","journal-title":"Hematol J"},{"key":"85_CR87","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1038\/sj.cdd.4401624","volume":"12 Suppl 1","author":"Y Kfoury","year":"2005","unstructured":"Kfoury Y, Nasr R, Hermine O, de The H, Bazarbachi A: Proapoptotic regimes for HTLV-I-transformed cells: targeting Tax and the NF-kappaB pathway. Cell Death Differ. 2005, 12 Suppl 1: 871-877. 10.1038\/sj.cdd.4401624","journal-title":"Cell Death Differ"}],"container-title":["AIDS Research and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1742-6405-5-12.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T01:44:24Z","timestamp":1630460664000},"score":1,"resource":{"primary":{"URL":"https:\/\/aidsrestherapy.biomedcentral.com\/articles\/10.1186\/1742-6405-5-12"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,6,10]]},"references-count":87,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,12]]}},"alternative-id":["85"],"URL":"https:\/\/doi.org\/10.1186\/1742-6405-5-12","relation":{},"ISSN":["1742-6405"],"issn-type":[{"value":"1742-6405","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,6,10]]},"assertion":[{"value":"28 November 2007","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 June 2008","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 June 2008","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"12"}}